248 related articles for article (PubMed ID: 26768655)
1. A novel diacylglycerol kinase α-selective inhibitor, CU-3, induces cancer cell apoptosis and enhances immune response.
Liu K; Kunii N; Sakuma M; Yamaki A; Mizuno S; Sato M; Sakai H; Kado S; Kumagai K; Kojima H; Okabe T; Nagano T; Shirai Y; Sakane F
J Lipid Res; 2016 Mar; 57(3):368-79. PubMed ID: 26768655
[TBL] [Abstract][Full Text] [Related]
2. Diacylglycerol kinase α-selective inhibitors induce apoptosis and reduce viability of melanoma and several other cancer cell lines.
Yamaki A; Akiyama R; Murakami C; Takao S; Murakami Y; Mizuno S; Takahashi D; Kado S; Taketomi A; Shirai Y; Goto K; Sakane F
J Cell Biochem; 2019 Jun; 120(6):10043-10056. PubMed ID: 30536880
[TBL] [Abstract][Full Text] [Related]
3. Combined inhibition/silencing of diacylglycerol kinase α and ζ simultaneously and synergistically enhances interleukin-2 production in T cells and induces cell death of melanoma cells.
Takao S; Akiyama R; Sakane F
J Cell Biochem; 2021 May; 122(5):494-506. PubMed ID: 33399248
[TBL] [Abstract][Full Text] [Related]
4. Palmitic acid- and/or palmitoleic acid-containing phosphatidic acids are generated by diacylglycerol kinase α in starved Jurkat T cells.
Murakami Y; Murakami C; Hoshino F; Lu Q; Akiyama R; Yamaki A; Takahashi D; Sakane F
Biochem Biophys Res Commun; 2020 May; 525(4):1054-1060. PubMed ID: 32184022
[TBL] [Abstract][Full Text] [Related]
5. Identification of ritanserin analogs that display DGK isoform specificity.
Granade ME; Manigat LC; Lemke MC; Purow BW; Harris TE
Biochem Pharmacol; 2022 Mar; 197():114908. PubMed ID: 34999054
[TBL] [Abstract][Full Text] [Related]
6. Dual activities of ritanserin and R59022 as DGKα inhibitors and serotonin receptor antagonists.
Boroda S; Niccum M; Raje V; Purow BW; Harris TE
Biochem Pharmacol; 2017 Jan; 123():29-39. PubMed ID: 27974147
[TBL] [Abstract][Full Text] [Related]
7. Evaluations of the selectivities of the diacylglycerol kinase inhibitors R59022 and R59949 among diacylglycerol kinase isozymes using a new non-radioactive assay method.
Sato M; Liu K; Sasaki S; Kunii N; Sakai H; Mizuno H; Saga H; Sakane F
Pharmacology; 2013; 92(1-2):99-107. PubMed ID: 23949095
[TBL] [Abstract][Full Text] [Related]
8. The Roles of Diacylglycerol Kinase α in Cancer Cell Proliferation and Apoptosis.
Sakane F; Hoshino F; Ebina M; Sakai H; Takahashi D
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680338
[TBL] [Abstract][Full Text] [Related]
9. Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program.
Arranz-Nicolás J; Martin-Salgado M; Adán-Barrientos I; Liébana R; Del Carmen Moreno-Ortíz M; Leitner J; Steinberger P; Ávila-Flores A; Merida I
Cancer Immunol Immunother; 2021 Nov; 70(11):3277-3289. PubMed ID: 33837851
[TBL] [Abstract][Full Text] [Related]
10. Molecular Pathways: Targeting Diacylglycerol Kinase Alpha in Cancer.
Purow B
Clin Cancer Res; 2015 Nov; 21(22):5008-12. PubMed ID: 26420856
[TBL] [Abstract][Full Text] [Related]
11. Selectivity of the diacylglycerol kinase inhibitor 3-[2-(4-[bis-(4-fluorophenyl)methylene]-1-piperidinyl)ethyl]-2, 3-dihydro-2-thioxo-4(1H)quinazolinone (R59949) among diacylglycerol kinase subtypes.
Jiang Y; Sakane F; Kanoh H; Walsh JP
Biochem Pharmacol; 2000 Apr; 59(7):763-72. PubMed ID: 10718334
[TBL] [Abstract][Full Text] [Related]
12. Diacylglycerol kinase alpha activity promotes survival of CD4+ 8+ double positive cells during thymocyte development.
Outram SV; Crompton T; Merida I; Varas A; Martinez-A C
Immunology; 2002 Apr; 105(4):391-8. PubMed ID: 11985659
[TBL] [Abstract][Full Text] [Related]
13. Screening of subtype-specific activators and inhibitors for diacylglycerol kinase.
Hayashi D; Tsumagari R; Liu K; Ueda S; Yamanoue M; Sakane F; Shirai Y
J Biochem; 2019 Jun; 165(6):517-522. PubMed ID: 30715374
[TBL] [Abstract][Full Text] [Related]
14. Fatty acids inhibit growth-factor-induced diacylglycerol kinase alpha activation in vascular smooth-muscle cells.
Du X; Jiang Y; Qian W; Lu X; Walsh JP
Biochem J; 2001 Jul; 357(Pt 1):275-82. PubMed ID: 11415460
[TBL] [Abstract][Full Text] [Related]
15. Diacylglycerol kinase alpha suppresses tumor necrosis factor-alpha-induced apoptosis of human melanoma cells through NF-kappaB activation.
Yanagisawa K; Yasuda S; Kai M; Imai S; Yamada K; Yamashita T; Jimbow K; Kanoh H; Sakane F
Biochim Biophys Acta; 2007 Apr; 1771(4):462-74. PubMed ID: 17276726
[TBL] [Abstract][Full Text] [Related]
16. Diacylglycerol kinases in cancer.
Mérida I; Torres-Ayuso P; Ávila-Flores A; Arranz-Nicolás J; Andrada E; Tello-Lafoz M; Liébana R; Arcos R
Adv Biol Regul; 2017 Jan; 63():22-31. PubMed ID: 27697466
[TBL] [Abstract][Full Text] [Related]
17. Role of diacylglycerol kinase alpha in the attenuation of receptor signaling.
Sanjuán MA; Jones DR; Izquierdo M; Mérida I
J Cell Biol; 2001 Apr; 153(1):207-20. PubMed ID: 11285286
[TBL] [Abstract][Full Text] [Related]
18. Epitope Mapping of Antidiacylglycerol Kinase α Monoclonal Antibody DaMab-2.
Sano M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2019 Feb; 38(1):8-11. PubMed ID: 30648914
[TBL] [Abstract][Full Text] [Related]
19. Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals.
Arranz-Nicolás J; Ogando J; Soutar D; Arcos-Pérez R; Meraviglia-Crivelli D; Mañes S; Mérida I; Ávila-Flores A
Cancer Immunol Immunother; 2018 Jun; 67(6):965-980. PubMed ID: 29572701
[TBL] [Abstract][Full Text] [Related]
20. Establishment and Epitope Mapping of Anti-Diacylglycerol Kinase α Monoclonal Antibody DaMab-8 for Immunohistochemical Analyses.
Sano M; Kaneko MK; Suzuki H; Kato Y
Monoclon Antib Immunodiagn Immunother; 2020 Feb; 39(1):1-5. PubMed ID: 31099705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
